APA (7th ed.) Citation

F, B., J, H., P, S., N, B., O, K., OA, C., & D, T. (2018). (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): Study protocol for a randomized controlled trial. Trials, 19(1), 472. https://doi.org/10.1186/s13063-018-2868-0

Chicago Style (17th ed.) Citation

F, Bloos, Held J, Schlattmann P, Brillinger N, Kurzai O, Cornely OA, and Thomas-Rüddel D. "(1,3)-β-D-glucan-based Diagnosis of Invasive Candida Infection Versus Culture-based Diagnosis in Patients with Sepsis and with an Increased Risk of Invasive Candida Infection (CandiSep): Study Protocol for a Randomized Controlled Trial." Trials 19, no. 1 (2018): 472. https://doi.org/10.1186/s13063-018-2868-0.

MLA (9th ed.) Citation

F, Bloos, et al. "(1,3)-β-D-glucan-based Diagnosis of Invasive Candida Infection Versus Culture-based Diagnosis in Patients with Sepsis and with an Increased Risk of Invasive Candida Infection (CandiSep): Study Protocol for a Randomized Controlled Trial." Trials, vol. 19, no. 1, 2018, p. 472, https://doi.org/10.1186/s13063-018-2868-0.